Macular pigment distribution as prognostic marker for disease progression in macular telangiectasia type 2 Simone Müller, Peter Charbel Issa, Tjebo F.C. Heeren, SarahThiele, Frank G. Holz, Philipp Herrmann. American Journal of Ophthalmology, Volume 194, 2018, p. 163-169.
Genetic penetrance of macular telangiectasia type 2 Cecinio C. Ronquillo, Kimberley Wegner, Charles M. Calvo, Paul S. Bernstein. JAMA Ophthalmology, 09 August 2018. doi:10.1001/jamaophthalmol.2018.3283
Retinal-choroidal anastomosis in macular telangiectasia type 2 Spaide, Richard F., Yannuzzi, Lawrence A., Maloca, Peter M. Retina, 08 August 2018. doi: 10.1097/IAE.0000000000002289
Contrast sensitivity and visual acuity under low light conditions in macular telangiectasia type 2 Simone Müller, Tjebo F C Heeren, Roberto Bonelli, Marcus Fruttiger, Peter Charbel Issa, Catherine A Egan, Frank G Holz. British Journal of Ophthalmology. 01 June 2018. doi: 10.1136/bjophthalmol-2017-311785
Fundus-wide subretinal and pigment epithelial abnormalities in macular telangiectasia type 2 Powner MB, Woods SM, Zhu M, Gillies MC, Bernstein PS, Hageman GS, Comer GM, Egan C, Fruttiger M. Retina. 2018 Jan;38 Suppl 1:S105-S113. doi: 10.1097/IAE.0000000000001860.
Macular telangiectasia type 2: Quantitative analysis of a novel phenotype and implications for the pathobiology of the disease Okada M, Egan CA, Heeren TFC, Tufail A, Fruttiger M, Maloca PM. Retina. 2018 Jan;38 Suppl 1:S97-S104. doi: 10.1097/IAE.0000000000001812.
Effect of dark adaptation and bleaching on blue light reflectance imaging in macular telangiectasia type 2 Okada M, Heeren TFC, Egan CA, Rocco V, Bonelli R, Fruttiger M. Retina. 2018 Jan;38 Suppl 1:S89-S96. doi: 10.1097/IAE.0000000000001754.
Abnormal retinal reflectivity to short-wavelength light in type 2 idiopathic macular telangiectasia Sallo FB, Leung I, Zeimer M, Clemons TE, Dubis AM, Fruttiger M, Pauleikhoff D, Chew EY, Egan C, Peto T, Bird AC; MacTel Study Group. Retina. 2018 Jan;38 Suppl 1:S79-S88. doi: 10.1097/IAE.0000000000001728.
Concurrent idiopathic macular telangiectasia type 2 and central serous chorioretinopathy Matet A, Yzer S, Chew EY, Daruich A, Behar-Cohen F, Spaide RF. Retina. 2018 January;38 Suppl 1:S67-S78. doi: 10.1097/IAE.0000000000001836.
Sex steroids and macular telangiectasia type 2 Müller S, Allam JP, Bunzek CG, Clemons TE, Holz FG, Charbel Issa P. Retina. 2018 January; 38 Suppl 1:S61-S66. doi: 10.1097/IAE.0000000000001789.
